November 13, 2026
OMNI INDUSTRIES LIMITED (OMNI)
Unaudited financials for the nine months ended September 30, 2026:
OMNI Industries Limited (OMNI) for the nine months ended September 30, 2026, reported a 23% increase in Revenue totaling $1.93 billion compared to $1.58 billion in the corresponding period last year, driven by accelerated sales volumes in the construction segment, which accounted for 57% of revenue. Revenue for the third quarter grew 3% to close at $602.65 million compared to $587.43 million for the comparable quarter of 2025.
Year-to-date, Cost of Sales amounted to $1.18 billion (2025: $926.06 million), reflecting a 28% increase year over year. Consequently, Gross Profit increased by 16% to $751.74 million compared to $649.54 million for the nine months ended September 30, 2025, while the gross profit margin narrowed to 38.89% from 41.23%, as supplier diversification, higher freight and fuel costs raised input costs. The company booked Gross Profit of $233.31 million for the third quarter versus $244.10 million reported for the similar quarter of 2025, a 4% decline.
Other Income increased by 9% to close at $24.69 million (2025: $22.68 million). Administrative Expenses rose 7% to $216.76 million (2025: $203.38 million), Selling Expenses increased 11% to $132.82 million (2025: $120.13 million), and Factory Expenses rose 25% to $229.48 million (2025: $183.75 million) on newly commissioned machinery. As a result, total operating expenses amounted to $579.06 million, a 14% increase relative to $507.25 million reported in 2025.
Operating Profit for the nine months amounted to $197.36 million, a 20% increase relative to $164.97 million reported in 2025, with the operating margin at 10.21% (2025: 10.47%). Operating Profit for the third quarter amounted to $39.44 million (2025: $67.83 million), a 42% decrease. Net Finance Costs totaled $28.60 million, a 19% increase from $24.10 million in the corresponding period last year; for the third quarter they were $13.23 million, up 42% from $9.34 million.
Profit before Taxation for the nine months ended September 30, 2026, amounted to $168.76 million, a 20% increase relative to $140.87 million reported in 2025. Profit before Taxation for the third quarter amounted to $26.21 million (2025: $58.49 million).
No tax charge was incurred for the nine months (2025: nil), the company being within its Junior Market exemption. As a result, Net Profit for the nine months amounted to $168.76 million, a 20% increase from the $140.87 million reported in 2025. For the third quarter, Net Profit was $26.21 million (2025: $58.49 million), a 55% decline.
Consequently, Earnings Per Share for the nine months amounted to $0.068 (2025: EPS: $0.056), while Earnings Per Share for the quarter totaled $0.010 (2025: EPS: $0.023). The twelve-month trailing EPS was $0.07 and the number of shares used in these calculations was 2,500,000,000. Notably, OMNI’s stock price closed the trading period on November 13, 2026 at a price of $0.97 with a corresponding P/E ratio of 14.27x.
Balance Sheet Highlights
The company’s assets totalled $2.08 billion (2025: $1.80 billion), representing a 16% increase or $283.18 million year-over-year. The movement in total assets was primarily attributable to a 48% increase in Inventories amounting to $1.07 billion (2025: $723.60 million), while partially offset by a 12% decline in Receivables to $415.61 million (2025: $471.14 million) and a 3% decline in Property, Plant & Equipment to $571.45 million (2025: $586.64 million). Cash and Bank Balances rose 16% to $17.30 million (2025: $14.97 million).
Shareholders’ equity was $1.21 billion (2025: $1.07 billion), representing a book value per share of $0.48 (2025: $0.43). Retained earnings rose to $712.83 million (2025: $570.43 million), net of a $27.50 million dividend declared in September 2026 and paid on October 30, 2026.
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
